Furthermore, whilst there is some degree of uncertainty as to whether the chronic peripheral dose of losartan has central effects, the fact that the ICV dose does not produce a greater hypotensive effect compared with the SC dose suggests that greater central AT1 receptor activity does not contribute to the hypertension in BPH/2J mice. This evidence concerns the gene AGTR1 and benign prostatic hyperplasia.